Press Releases

Scar Treatment Market Size to Worth Around USD 56.3 Bn by 2030

The worldwide Scar Treatment market measurement is anticipated to achieve USD 56.3 billion by 2030 and is anticipated to increase at a CAGR of 15.1% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38460

Growth Factors

Scar treatment market is developing at a fast rate due to the growing awareness among people regarding aesthetics. Acne scars are one of the most common concerns. Rise in the number of road accidents also results in several marks, which many a time require surgical assistance.

Hence, patients who have undergone such surgeries are generally provided with topical products for scar reduction. Cosmetic surgeries with laser instruments are also being undertaken for treating severe marks from road accidents. To remove such marks, plastic surgeries or resurfacing laser therapies are being preferred. Technologically advanced scar removal products minimize pain and facilitate a hassle-free healing process. For instance, UltraPulse by Lumenis uses CO2 laser for the treatment of acne scars reduces the risk of pain during the treatment process. 

Report Highlights

Topical products held the largest share of 68.0% in 2020. The availability of topical gels, creams, and silicone sheets as Over-the-Counter (OTC) products enables individuals to utilize them as a treatment for scars. Laser products are also used extensively as they provide a non-invasive and painless alternative for the treatment of scars with minimal discomfort.

Atrophic scars held the largest share of 46.4% in 2020 due to the rising prevalence of acne scars. These scars are usually treated with topical creams and gels. Hypertrophic and keloid scars are anticipated to witness significant growth over the forecast period owing to their frequent occurrence among people with wound injuries.

The hospitals segment dominated the market with a share of 53.0% in 2020 owing to the usage of sophisticated infrastructure and the presence of technologically advanced products in these settings for scar treatment. The retail pharmacies/e-commerce segment is projected to witness the fastest growth over the forecast period due to the rapid growth of online websites and easy access to scar treatment products on these websites. The outbreak of COVID-19 is also expected to boost the growth of the segment.

North America dominated the market with a revenue share of 45.2% in 2020 owing to the high aesthetic consciousness among people and the rapid adoption of advanced products. In addition, advanced laser instruments for scar treatment are in high demand in the U.S.The U.S. held the largest share in the North American market in 2020. According to the American Burn Association (ABA), there are 486,000 burn cases annually.

Asia Pacific is expected to exhibit the highest CAGR of 21.4% over the forecast period due to the high incidence of road accidents in countries such as India. Key countries in the Asia Pacific market are India and China.

Key Players

  • Smith & Nephew PLC
  • Lumenis
  • Merz Pharmaceuticals, LLC
  • Sonoma Pharmaceuticals, Inc.
  • Cynosure
  • CCA Industries, Inc.
  • Newmedical Technology Inc.
  • Mölnlycke Health Care AB
  • Suneva Medical
Report Coverage Details
Market Size US$ 56.3 billion by 2030
Growth Rate CAGR of 15.1% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, Scar type, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Smith & Nephew PLC; Lumenis; Merz Pharmaceuticals, LLC; Sonoma Pharmaceuticals, Inc.; Cynosure; CCA Industries, Inc.; Newmedical Technology Inc.; Mölnlycke Health Care AB; Suneva Medical

Market Segmentation

  • Product
    • Topical Products
      • Creams
      • Gels
      • Silicon Sheets
      • Others
    • Laser Products
      • CO2 Laser
      • Pulse-dyed Laser
      • Others
    • Injectables
    • Others
  • Scar Type
    • Atrophic Scars
    • Hypertrophic and Keloid Scars
    • Contracture Scars
    • Stretch Marks
  • End-use
    • Hospitals
    • Clinics
    • Retail Pharmacies/ E-commerce
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
    • Asia Pacific
      • China
      • Japan
      • India
      • Singapore
      • South Korea
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38460

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Scar Treatment Market, By Product

7.1.  Scar Treatment Market, by Product, 2021-2030

7.1.1.    Topical Products

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Laser Products

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Injectables

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Scar Treatment Market, By Scar Type

8.1.  Scar Treatment Market, by Scar Type, 2021-2030

8.1.1.    Atrophic Scars

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Hypertrophic and Keloid Scars

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Contracture Scars

8.1.3.1.        Market Revenue and Forecast (2017-2030)

8.1.4.    Stretch Marks

8.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Scar Treatment Market, By End-use

9.1.  Scar Treatment Market, by End-use, 2021-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Clinics

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Retail Pharmacies/ E-commerce

9.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Scar Treatment Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product (2017-2030)

10.1.2.  Market Revenue and Forecast, by Scar Type (2017-2030)

10.1.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product (2017-2030)

10.2.2.  Market Revenue and Forecast, by Scar Type (2017-2030)

10.2.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product (2017-2030)

10.3.2.  Market Revenue and Forecast, by Scar Type (2017-2030)

10.3.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product (2017-2030)

10.4.2.  Market Revenue and Forecast, by Scar Type (2017-2030)

10.4.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product (2017-2030)

10.5.2.  Market Revenue and Forecast, by Scar Type (2017-2030)

10.5.3.  Market Revenue and Forecast, by End-use (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by End-use (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Scar Type (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by End-use (2017-2030)

Chapter 11.  Company Profiles

11.1.              Smith & Nephew PLC

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Lumenis

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Merz Pharmaceuticals, LLC

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Sonoma Pharmaceuticals, Inc.

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Cynosure

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              CCA Industries, Inc.

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Newmedical Technology Inc.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Mölnlycke Health Care AB

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Suneva Medical

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38460

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Show More

Related Articles

Back to top button